These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25956160)

  • 21. [Neurological complications in legionnaires' disease].
    Hamburger HL; Op de Coul AA; van Luijk JH; Palmen FM; van Puyenbroek MJ
    Ned Tijdschr Geneeskd; 1982 Sep; 126(36):1622-5. PubMed ID: 7133204
    [No Abstract]   [Full Text] [Related]  

  • 22. Fixed drug eruption caused by piperacillin-tazobactam.
    Santosa A; Teo BW; Shek LP
    J Investig Allergol Clin Immunol; 2013; 23(2):132-3. PubMed ID: 23654084
    [No Abstract]   [Full Text] [Related]  

  • 23. Fever of unknown origin due to Legionnaires' disease: A diagnostic challenge.
    Kampitak T
    Travel Med Infect Dis; 2018; 22():79. PubMed ID: 29412169
    [No Abstract]   [Full Text] [Related]  

  • 24. An atypical complication of atypical pneumonia.
    Antonarakis ES; Wung PK; Durand DJ; Leyngold I; Meyerson DA
    Am J Med; 2006 Oct; 119(10):824-7. PubMed ID: 17000209
    [No Abstract]   [Full Text] [Related]  

  • 25. [The legionnaires' disease. Report of a case in a patient from the province of Madrid with a chronic lymphatic leukemia (author's transl)].
    Zabala P; Frieyro E; Bouza E; Rodriguez Creixems M; Barbolla L; Sanjuán I; Buzón L; Masa C; Pérez Maestu R; Fernández MN
    Med Clin (Barc); 1979 Jun; 73(1):1-4. PubMed ID: 470498
    [No Abstract]   [Full Text] [Related]  

  • 26. Legionnaires' disease. Report of a case.
    Kang XM; Xia XR; Tang ZQ
    Chin Med J (Engl); 1983 Feb; 96(2):151-3. PubMed ID: 6406173
    [No Abstract]   [Full Text] [Related]  

  • 27. [Legionnaires' disease: clinical aspects of complications, treatment and prognosis].
    Temezhnikova ND; Sinopal'nikov AI
    Voen Med Zh; 2008 Feb; 329(2):54-8. PubMed ID: 18416114
    [No Abstract]   [Full Text] [Related]  

  • 28. De novo generalised non-convulsive status epilepticus triggered by piperacillin/tazobactam.
    Fernández-Torre JL; Santos-Sánchez C; Pelayo AL
    Seizure; 2010 Oct; 19(8):529-30. PubMed ID: 20674399
    [No Abstract]   [Full Text] [Related]  

  • 29. Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children.
    Patel A; Mao KR; McNeil JC; Kaplan SL; Vallejo JG
    Pediatr Infect Dis J; 2015 Aug; 34(8):849-50. PubMed ID: 25961892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review.
    Saito-Sasaki N; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Okada E; Nakamura M
    Eur J Dermatol; 2017 Feb; 27(1):88-89. PubMed ID: 27748262
    [No Abstract]   [Full Text] [Related]  

  • 31. Legionnaires' disease in the postoperative patient.
    Serota AI; Meyer RD; Wilson SE; Edelstein PH; Finegold SM
    J Surg Res; 1981 May; 30(5):417-27. PubMed ID: 7242059
    [No Abstract]   [Full Text] [Related]  

  • 32. Legionnaire's disease presenting as fulminating respiratory failure.
    Tawadros HH; Thiagarajan D; Mukherji BB
    J Kans Med Soc; 1982 Jan; 83(1):11-4. PubMed ID: 7054343
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug fever caused by piperacillin-tazobactam.
    Linares T; Fernández A; Soto MT; Escudero E; Gacías L
    J Investig Allergol Clin Immunol; 2011; 21(3):250-1. PubMed ID: 21548459
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hairy cell leukaemia and Legionnaires' disease.
    Chowdhury VJ; Oscier DG; Mufti GJ; Hamblin TJ
    Br J Dis Chest; 1985 Oct; 79(4):393-5. PubMed ID: 4052311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute generalized exanthematous pustulosis caused by piperacillin/tazobactam.
    Grieco T; Cantisani C; Innocenzi D; Bottoni U; Calvieri S
    J Am Acad Dermatol; 2005 Apr; 52(4):732-3. PubMed ID: 15793550
    [No Abstract]   [Full Text] [Related]  

  • 37. Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report.
    Calogiuri GF; Nettis E; Di Leo E; Vacca A; Ferrannini A; Kounis NG
    Int J Cardiol; 2012 Mar; 155(3):e42-4. PubMed ID: 21839530
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
    Gomes DM; Smotherman C; Birch A; Dupree L; Della Vecchia BJ; Kraemer DF; Jankowski CA
    Pharmacotherapy; 2014 Jul; 34(7):662-9. PubMed ID: 24753221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Legionnaires disease presenting as acute kidney injury in the absence of pneumonia.
    Yogarajah M; Sivasambu B
    BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25691580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Legionnaires' disease in Hodgkin's disease].
    Dreyfus B; Leporrier M; Dournon E; Vernant JP; Autran B; Debré PP; Goris C; Binet JL
    Nouv Rev Fr Hematol (1978); 1982; 24(5):315-9. PubMed ID: 7167383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.